Evaluation of Topoisomerase I Levels in Ovarian Cancer Cells after Variable Times of Exposure to Topotecan

Grants and Contracts Details

StatusFinished
Effective start/end date2/15/022/14/03

Funding

  • GlaxoSmithKline: $38,042.00